| PLGA-based nanoparticles: an overview of biomedical applications F Danhier, E Ansorena, JM Silva, R Coco, A Le Breton, V Préat Journal of controlled release 161 (2), 505-522, 2012 | 3742 | 2012 |
| To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery F Danhier, O Feron, V Préat Journal of controlled release 148 (2), 135-146, 2010 | 2998 | 2010 |
| To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? F Danhier Journal of Controlled Release 244, 108-121, 2016 | 1205 | 2016 |
| RGD-based strategies to target alpha (v) beta (3) integrin in cancer therapy and diagnosis F Danhier, A Le Breton, V Préat Molecular pharmaceutics 9 (11), 2961-2973, 2012 | 1027 | 2012 |
| Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation F Danhier, N Lecouturier, B Vroman, C Jérôme, J Marchand-Brynaert, ... Journal of controlled release 133 (1), 11-17, 2009 | 715 | 2009 |
| Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel F Danhier, B Vroman, N Lecouturier, N Crokart, V Pourcelle, H Freichels, ... Journal of Controlled Release 140 (2), 166-173, 2009 | 424 | 2009 |
| Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures H Ragelle, F Danhier, V Préat, R Langer, DG Anderson Expert opinion on drug delivery 14 (7), 851-864, 2017 | 362 | 2017 |
| Vitamin E-based nanomedicines for anti-cancer drug delivery N Duhem, F Danhier, V Préat Journal of Controlled Release 182, 33-44, 2014 | 257 | 2014 |
| Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging N Schleich, P Sibret, P Danhier, B Ucakar, S Laurent, RN Muller, ... International journal of pharmaceutics 447 (1-2), 94-101, 2013 | 244 | 2013 |
| Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy N Schleich, C Po, D Jacobs, B Ucakar, B Gallez, F Danhier, V Préat Journal of Controlled Release 194, 82-91, 2014 | 242 | 2014 |
| Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma C Bastiancich, P Danhier, V Préat, F Danhier Journal of Controlled Release 243, 29-42, 2016 | 236 | 2016 |
| Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment LP Ganipineni, F Danhier, V Préat Journal of controlled release 281, 42-57, 2018 | 175 | 2018 |
| Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection C Bastiancich, J Bianco, K Vanvarenberg, B Ucakar, N Joudiou, B Gallez, ... Journal of controlled release 264, 45-54, 2017 | 131 | 2017 |
| Iron oxide-loaded nanotheranostics: Major obstacles to in vivo studies and clinical translation N Schleich, F Danhier, V Préat Journal of Controlled Release 198, 35-54, 2015 | 118 | 2015 |
| Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma C Bastiancich, K Vanvarenberg, B Ucakar, M Pitorre, G Bastiat, F Lagarce, ... Journal of controlled release 225, 283-293, 2016 | 116 | 2016 |
| Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma T Fourniols, LD Randolph, A Staub, K Vanvarenberg, JG Leprince, ... Journal of Controlled Release 210, 95-104, 2015 | 111 | 2015 |
| Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation F Danhier, K Messaoudi, L Lemaire, JP Benoit, F Lagarce International journal of pharmaceutics 481 (1-2), 154-161, 2015 | 104 | 2015 |
| Modeling of the burst release from PLGA micro-and nanoparticles as function of physicochemical parameters and formulation characteristics CR de Azevedo, M von Stosch, MS Costa, AM Ramos, MM Cardoso, ... International journal of pharmaceutics 532 (1), 229-240, 2017 | 98 | 2017 |
| Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection M Zhao, E Bozzato, N Joudiou, S Ghiassinejad, F Danhier, B Gallez, ... Journal of controlled release 309, 72-81, 2019 | 96 | 2019 |
| Self-Assembling Doxorubicin–Tocopherol Succinate Prodrug as a New Drug Delivery System: Synthesis, Characterization, and in Vitro and in Vivo Anticancer … N Duhem, F Danhier, V Pourcelle, JM Schumers, O Bertrand, CS LeDuff, ... Bioconjugate chemistry 25 (1), 72-81, 2014 | 90 | 2014 |
